Bob Gokani entered the Den with Ezidrops, a clever solution to the universal struggle of self-administering eye and ear drops without the mess or the “blink reflex”. Despite having impressive retail traction in Boots and a massive order from Walgreens in the US, the entrepreneur faced a grueling interrogation from the Dragons over his intellectual property and the simplicity of his plastic applicators. The segment reaches a fever pitch when Gokani is presented with a life-changing investment offer that comes at a steep price: 40% of his business. His decision to turn down two of the UK’s most powerful investors to protect his equity is a masterclass in founder confidence, proving that sometimes the best deal you can make is the one you walk away from.